Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014623

SVP, Chief Business Officer acquired 47,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mitchener Stephen SVP, Chief Business Officer 2022-02-28 Grant or award +47,250 50,546 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mitchener Stephen SVP, Chief Business Officer 2022-02-28 Grant or award · Stock Option (right to buy) +59,400 59,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…